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(57) ABSTRACT 
Kay den, 
Disclosed are portable, disposable, centimeter-scale, inte-
grated diagnostics incubators for use in biological culturing. 
An exemplary incubator comprises an optically accessible 
enclosure having a plurality of fluidic ports. A heating ele-
ment is disposed within the enclosure that is coupled to an 
external heater controller. An autoclavable microfluidic per-
fusion chamber is disposed within the enclosure that com-
prises a cell culture life support chamber, an inlet port dis-
posed in the perfusion chamber, a collection chamber in 
communication with the culture chamber, an outlet port 
coupled to the collection pool, and a perfusing substrate. An 
optically transparent, gas permeable membrane is attachable 
to the top of the perfusion chamber. The incubators have 
optical accessibility, forced flow fluidic control, temperature 
control, are portable and modular, and are inexpensively 
manufactured. The incubators permit in-the-field drug testing 
and culturing of biological tissues. 
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CENTIMETER-SCALE, INTEGRATED 
DIAGNOSTICS INCUBATOR FOR 
BIOLOGICAL CULTURING 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application claims priority to U.S. provisional appli-
cation entitled "LOW-COST, CENTIMETER-SCALE, 
INTEGRATED DIAGNOSTICS INCUBATOR FOR BIO-
LOGICAL CULTURING" having Ser. No. 60/697,437, filed 
Jul. 8, 2005. 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT 
This invention was made with govermnent support under 
agreement I ROI EB00786-01 awarded by the National Sci-
ence Foundation. The Government has certain rights in the 
invention. 
BACKGROUND 
The present invention relates generally to portable, diag-
nostics, pocket-size incubators with integrated perfusion, and 
more particularly, to a biocompatible, disposable, centimeter-
scale, incubator workstation 10 for in situ monitoring, han-
dling and scientific studies of biological cultures in the field 
and within major laboratories. 
2 
densities with the low number of cells. It would be desirable 
that the centimeter-scale diagnostics incubator has small 
overall dimensions that would facilitate the control of the 
cellular microenvironment and provide the shortest possible 
5 response time to the physical changes and chemical stimuli. It 
would also be desirable to have a centimeter-scale, integrated 
diagnostics incubator that is portable and may be used in the 
field. Ultimately, it would also be desirable to have a centi-
meter-scale, integrated diagnostics incubator of a modular 
10 design to address different demands. 
While 2-D culturing constitutes a standard practice for 
many fundamental studies, researchers are increasingly 
implementing the 3-D cell culture systems because they are 
biologically more realistic in capturing the in-vivo condition 
15 than their 2-D correlates. The three-dimensionality enables 
scientists to investigate cellular behavior in a more physi-
ologically relevant state, while preserving the primary advan-
tages of traditional in vitro systems, such as the control of 
cellular environment, accessibility for imaging, and elimina-
20 ti on of systemic effects. Cells cultured in a 3-D environment 
are found to better represent the in vivo cellular behavior than 
cells cultured in monolayers. This was shown for different 
kinds of cell lines, e.g. for fibroblasts cells by Grinnell F. in 
2000 Trends Cell Biol 10:362-365; for breast cells, e.g., Wang 
25 F. et al. in 1998 Proc NatlAcad Sci USA 95:14821-14826; for 
osteoblastic cells, by Granet C. et al. in 1998 Med Biol Eng 
Comput 36:513-519; and, neural cells by Fawcett J. W. et al. 
in 1989 Dev Biol 135:449-458, or Fawcett J. W. et al. in 1995 
Exp Brain Res 106:275-282. 
The way cells interact with each other and their microen-
vironment is fundamentally different in 3-D and 2-D cultures, 
see for example Schmeichel K. L. et al. in 2003, J Cell Sci 
11:2377-2388. In many cases these interactions are reduced 
or negligible in 2-D cultures. This necessitated the develop-
Currently, the handling of biological samples intended for 30 
experimentation and diagnostic analysis is often limited by 
the need to carefully manage the conditions of perfusion and 
incubation, and to quickly return the samples to a controlled 
environment, especially in field situations. In many cases, 
necessary manipulation of samples for analytical purposes 
can result in unwanted contamination, lost time and consid-
erable costs associated with repeat experiments. 
35 ment of neural cell culture models to support high, 3-D cel-
lular densities with cells evenly distributed throughout the 
full thickness of the matrix. The extracellular matrix material 
supports the cells in a 3-D setting, and, enhances cell-to-cell 
and cell-to-matrix interactions, e.g., O'Connor S. M. et al. in 
40 2001 Neurosci Lett 304:189-193; Woerly S. et al. in 1996 
Neurosci Lett 205:197-201. However, these cultures have 
relied on passive diffusion for nutrient delivery and removal 
of toxic waste products necessitating the use of cell densities 
much lower than those found in the brain for example. There-
Conventional incubators are relatively large devices, hav-
ing a size that is comparable to a small bar refrigerator. 
Typically, static cultures are formed on Petri dishes and then 
placed in the incubator on shelves. While the incubator may 
typically have temperature, humidity and gas control, there is 
generally no provision for optically inspecting the cultures 
without opening the incubator and removing the Petri dish 
from the incubator. This exposes the culture to possible con-
tamination, and may cause other problems relating to culture 
growth. Hence, it would be desirable to have an improved 
centimeter-scale, diagnostics incubator with integrated per-
fusion that may be used to culture biological samples with the 
better control of the cellular micro-environment. It would also 50 
be desirable to have a centimeter-scale, integrated diagnostics 
incubator that permits in-situ optical inspection of cultures 
within the incubator. 
45 fore, diffusion limited mass transport in nutrient delivery 
prevented the development of more in vivo resembling 3-D 
neural cell culture models having high cellular density (~ 104 
cells/mm3 ) and uniform cell distribution throughout culture 
thickness (>500 µm). 
Growing demands for long-term incubation of physiologi-
cally faithful, three-dimensional (3-D) neuronal and other 
cultures during extended physiological studies require effi-
cient perfusion platforms with functional vasculatures that 
mimic the in vivo condition in a thermally regulated environ-Experiments involving physiologically faithful, thick, 
three-dimensional (3-D) in-vitro cultures are time con-
strained as the tissue decays metabolically in the absence of 
functional vasculature and perfusion, often well before the 
relevant studies have been completed. Thus, it would be desir-
able to a have a centimeter scale diagnostic incubator with 
integrated perfusion that prevents high-density cultures from 
decaying metabolically by actively controlling the nutrient 
medium exchange rate and enabling the forced convection, 
intercellular mass transport to overcome diffusion limits in 
nutrient and gas delivery through the culture. 
55 ment. While expensive, relatively small, incubation baths 
with thermostatically controlled water jackets and capillary 
action perfusion are available commercially, to date, they 
remain incompatible with the microfabrication processes 
with their use confined to specific experimental conditions 
60 associated with the limits of capillary action perfusion. Rep-
resentative incubation baths with passive perfusion are dis-
closed by Haas H. L. et al. in 1979 J Neurosci Meth 1:323-
325, and, Zbicz K. L. et al. in 1985 J Neurophysiol 53: 1038-
1058. 
Since high-density cultures require many cells it would be 65 
desirable that the size of the cell culture chamber be as small 
The widespread use of 3-D neural cultures in medical 
research, however, is often hindered by low water solubility 
of oxygen, limited diffusion of media and oxygen through the as possible to reduce expenditures and enable high-plating 
US 7,855,070 B2 
3 
tissue, and poor waste removal. Once the slices are being 
harvested, the utility of experiments is restricted by the qual-
ity of tissue perfusion, as the success of electrophysiological 
studies, for example, depends on long term slice viability to 
take reliable recordings. 
There are generally two kinds of perfusion chambers that 
are being used to extend the viability of acute tissue slices in 
vitro based on constant circulation of the culture medium by 
passively augmenting the supply of media and oxygen. In the 
first kind, the tissue is submersed in the bathing solution and 10 
perfused using oxygenated media as discussed by Richards C. 
D. et al. in 1977 Br J Pharmacol 59:526P; Nicoll R.A. et al. in 
1981 JNeurosci Meth4:153-156; PalovcikR.A. eta!. in 1986 
J Neurosci Meth 17:129-139; Shi W. X. et al. in 1990 J 
Neurosci Meth 35:235-240, for example. In the second kind, 15 
the tissue rests on a mesh at the interface between the open 
channel flow of perfusate, underneath the mesh holding the 
tissue, and oxygenated and humidified atmosphere above the 
mesh. Representative chambers are described by Li C. L. et 
al. in 1957 J Physiol-London 139:178-190; Reynaud J.C. et 20 
al. in 1995 J Neurosci Meth. 58:203-208; Krimer L. Set al. in 
1997 J Neurosci Meth 75:55-58. 
4 
FIG. 2 is a top view of an exemplary microfluidic perfusion 
chamber that may be used in the diagnostics incubator and 
that comprises a culture chamber with fluidic ports and 
attached semi-permeable membrane that encapsulates the 
structure; 
FIGS. 3 and 4 illustrate three-dimensional views of the 
exemplary perfusion chamber; 
FIG. 5 is a cross-sectional view of the exemplary perfused 
culture chamber with integrated microfluidics; 
FIG. 6 is a top view showing details of a cell culture life 
support chamber centrally integrated within the perfusion 
platform; 
FIG. 7 illustrates an exemplary microscope stage insert 
plate that can be used to attach the centimeter scale incubator 
with an integrated perfusion chamber onto a microscope 
stage; 
FIG. 8 illustrates an exemplary in-line auto-venting aerator 
and bubble trap; 
FIGS. 9a-l show particle image velocimetry measurements 
of the induced flow within the culture chamber at different 
elevations parallel to the perfusing substrate; 
Both approaches have practical benefits and shortcomings. 
The principal advantage of the submerged tissue incubation is 
faster diffusion of the bathing solution into the slice than in 
interface type chambers where only one side of the tissue is 
exposed to the media, not both. Although intuitively tissue 
would seem to have better oxygenation lying at the interface 
than being submerged, due to limited water solubility of 
oxygen in the latter, Craning M. D. R. et al. in 1998 JN eurosci 
Meth 81: 103-11 found that the degree of disruption of ionic 
homeostatis by anoxia in rat hippocampal slices was greater 
when they were maintained at the interface. This could be 
attributed to the discontinuities in the flow of media associ-
ated with the surface tension effects at the gas-liquid inter-
face. In addition to being simpler to design, submerged cham-
bers provide more constant environment with less 
perturbations in fluid flow, purging of bubbles, and, draining, 
and, permit rapid exchanges of the bathing medium. Hence it 
appears that better perfusion fixation, in preventing both the 
starvation and anoxia during the process of observation, can 
be achieved in submerged chambers. Still, a major drawback 
FIG. 10 shows graphs that illustrate thermocouple tem-
perature measurements following an initial 10-minute long 
25 controller auto-tuning; 
FIG. 11 shows graphs that illustrate temperature measure-
ments while the incubator is in operation; and 
FIG. 12 illustrates a disposable thermoplastic master 
formed by solid object printing for use in elastomeric mold-
30 ing of perfusion chambers. 
DETAILED DESCRIPTION 
35 
To overcome problems associated with conventional incu-
bator technologies, and referring to the drawing figures, dis-
closed is a biocompatible, centimeter-scale, diagnostics incu-
bator 10 having an integrated microfluidic perfusion chamber 
30 which allows simultaneous culturing and experiments on a 
40 
bench top or a microscope stand, with full control of the 
environmental conditions, fluidic, optical, and, electrical 
accessibility. By way of illustration, FIG. 1 shows an exem-
plary centimeter-scale, integrated diagnostics incubator 10 
comprising an exemplary integrated perfusion chamber 30. 
in submerging the tissue below the liquid surface is actually 
keeping it submerged, because it will float unless it is properly 
attached to the perfusing substrate or restrained otherwise. In 45 
addition, localized injection of drugs is virtually impossible 
As is shown in FIG. 1, an exemplary reduced-to-practice 
centimeter-scale, integrated diagnostics incubator 10, or 
mini-incubator 10, comprises a biocompatible, polystyrene, 
heated enclosure 11 with exemplary outside dimensions of 
5.lx2.5xl.8 cm (LxWxD). The enclosure 11 has a removable 
top cover that facilitates the integration and packaging. 
Owing to the clarity of the polystyrene material, all surfaces 
to administer with the current designs. 
The dominant mode of mass transport in these scarcely 
used chambers remains diffusion and/or capillary action to 
passively augment the supply of media and oxygen to the 50 
tissue that eventually runs down metabolically. However, to 
meet and exceed the metabolic requirements for nutrient 
delivery and catabolic waste removal, mass transport by pure 
diffusion becomes insufficient and demands a convective 
enhancement for an adequate, dynamic, long-term control of 55 
the culture condition. 
BRIEF DESCRIPTION OF THE DRAWINGS 
of the enclosure 11 are optically transparent and enable visual 
inspection. 
The incubator 10 houses a biocompatible polydimethylsi-
loxane (PDMS), for example, perfusion chamber 30 with a 
centrally placed cell culture life support perfusion chamber 
20, a semi-permeable membrane aerator 21, a miniature, thin 
flexible heater 16 that maintains a desired temperature within 
the incubator 10 or heated enclosure 11, an in-line venting 
The various features, functionalities and practical advan-
tages of the present invention may be more readily under-
stood with reference to the following detailed description 
taken in conjunction with the accompanying drawings, 
wherein like reference numerals designate like structural ele-
ments, and in which: 
60 bubble trap 26 and a membrane aerator 27 for injected nutri-
ent medium, thermocouple sensors connected to a tempera-
ture controller 18, and; pertinent gas 12, 13 and fluidic inter-
faces 24, 25. The optically clear incubator enclosure 11 and a 
semi-permeable membrane aerator 21 permit optical exami-
FIG. 1 is a top view of an exemplary centimeter-scale, 
diagnostics incubator with integrated perfusion; 
65 nation or observation of a culture growing within the culture 
chamber 20. Imaging accessible, semi-permeable membrane 
21 (aerator 21 or oxygenator 21), located on the top of the 
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perfusion chamber 30, ensures sufficient gas delivery and 
provides sterile, moist microenvironment of appropriate acid-
ity. 
On the sides of the heated enclosure 11 there are separate 
gas connectors that enable the appropriate gas mixture to 
enter and leave the incubator 10 at a desired volume flow rate. 
6 
plug-in functionalities into the mini-incubator 10 tailored to 
specific use in a short tum-around time. 
The disclosed fluidic design also enables the introduction 
of externally controlled temporally varying 41, or, spatially 
varying, temporally invariant concentration gradients 42 of 
injected agents into the culture chamber 20, with fluidic infra-
structure and control located outside of the incubator enclo-
sure 11. Owing to the flexibility of the perfusion system, the 
A forced convection flow of gases, such as 95%/5% oxygen/ 
carbon dioxide mixture for example, enters tough gas inlet 12 
and outlet port 13. The gas inlet 12 and outlet 13 ports are 
coupled to gas lines 14 that lead to a separate miniature box 
(not shown) that houses a fan 19 and contains prescribed gas 
mixture via shut-off valve connection to a gas tank. A fan 19 
can be a pair of miniature blowers with the overall dimensions 
of 4 cmx4 cmx4 cm used in electronics cooling (Thermaltake 
A1899, for example). Blowers force the appropriate gas mix-
ture through the gas lines 14 and optically clear enclosure 11 
and allow external control of the fan speed to provide an 
optimal gas rate at a minimal noise level. 
10 
nature of cell feedings can be radically changed. For example, 
a programmable time-periodic injection of nutrients can be 
employed, followed by times where perfusion chamber 30 
acts as a static control; the media could also be cycled in and 
out of the chamber 30 in some periodic or aperiodic fashion to 
15 break the temporal invariance of spatial gradients; or, the ratio 
of fresh to used media can be varied to increase the amount of 
There are two fluidic interfaces for the nutrient medium, 
for example. They are associated with continuous infusion of 20 
the nutrients into the perfusion chamber 30 and withdrawal of 
used media and metabolic waste products at the same rate. All 
fluidic components (perfusion chamber 30, aerators, fittings 
and tubes) are steam autoclavable (re-usable) with stiff 
microbore tubes fabricated in an inert (Teflon FEP) material 25 
that minimizes the problems associated with bio-fouling 
(non-specific protein adhesion along the inner walls). Fluidic 
inlet and outlet ports 24, 25 are coupled to the infusion and 
withdrawal side of the syringe pump moving block respec-
tively. An exemplary syringe pump l9a with opposing 30 
syringes on a single drive may be a KdScientific pump model 
KDS210, for example. The pump mode of operation pertinent 
to the particular cell feeding schedule is externally controlled 
and can be a continuous infusion and withdrawal; program-
mable, time-periodic or aperiodic infusion and withdrawal; 35 
or, push/pull; with or without the re-use of spent perfusate. In 
either mode, while one syringe infuses the media, the other 
syringe withdraws the perfusate at the same rate so that the 
pressure within the cell culture chamber 20 remains at or near 
the atmospheric level. This particular mode protects the cul- 40 
tures from prohibitively high pressures otherwise associated 
with the return flow from the chamber. In a portable design, 
syringe pump l9a can be replaced with a pair of miniature 
piezoelectric pumps that can be battery operated (e.g. only 
0.15 W of power for Clark DTI-200-12P measuring 4-5 cm) 45 
and fluid delivery rates manipulated by varying the amplitude 
or the frequency, or both, of the power supplied using an 
inexpensive custom built function generator based on the 
operational amplifier circuits, for example. 
Unlike commercially available (Zbicz- or Haas-type) per- 50 
fusion chambers, disclosed manufacturable, cost efficient, 
disposable or autoclavable, microvascular perfusion cham-
bers 30 can be easily configured to meet specific demands 
while exceeding the available exchange rates of commercial 
devices by a few orders of magnitude. Fluidic functionality of 55 
the perfusion chamber 30 enables the culturing of thicker 
tissue slices and engineered 3-D culture models that better 
represent the in-vivo condition via forced convection inter-
cellular mass transport that is not feasible in commercially 
available interface or submerged-type perfusion chambers. A 60 
simple fabrication methodology based on elastomeric poly-
mer molding allows the integration of microfluidic and 
MEMS components (not shown) into the perfusion chamber 
30, such as micropumps, valves, mixers, microinjectors, cel-
lular manipulators or multielectrode arrays, for example. It 65 
also facilitates the interfacing of perfusion chambers 30 and 
incubators 10 and enables the integration of a number of 
cytokines (neurotrophins, for example) ifthe need arises. The 
fluidic system may be easily adapted to address and individu-
ally control multiple culture chambers 20 or perfusion cham-
bers 30. 
Drugs can be discretely applied to specific regions using 
separately addressable fluidic inputs, interfaced outside the 
incubator 10 and introduced into the perfusion chamber 30 
through the inlet port 33 (FIG. 5) or a plurality of inlet ports 
33 (not shown), as could other substances. This makes the 
centimeter-scale incubator 10 ideal for time-dependent phar-
macological studies at dynamically controlled exchange rates 
directly on a microscope stand, for example. Extra- and inter-
cellular ion concentration can be accurately controlled and 
easily altered. By collecting the spent perfusate, substances 
released during stimulation can be easily analyzed. Collected 
perfusate can be mixed with the fresh medium and re-used, 
particularly at high exchange rates and cell densities when 
neurotrophins may be depleting. 
The centimeter-scale incubator 10 with its integrated per-
fusion chamber 30 permits simultaneous studies of cell cul-
ture parameters using optical diagnostics. For this purpose, a 
particular microscope stage insert may be used. The incubator 
10 or perfusion chamber 30 connects directly to the micro-
scope stage insert plate by way of 4 screws and nuts that pass 
throughfourthrough-holes located on the body 31(FIG.2) of 
the perfusion chamber 30 and centimeter-scale incubator 10. 
This enables in situ cell culture viability studies and immu-
nocytochemistry, for example, below the microscope objec-
tive. An exemplary microscope stage insert, shown in FIG. 7, 
was built using stereolithography. 
A heating element 16, such as a miniature (2 cmx2.5 cm) 
resistive foil heater 16 (Minco HK5291, for example) is dis-
posed within the enclosure 11 and has the lead wires 17 
extending outside of the enclosure 11 to a temperature con-
troller 18 coupled to a DC switching relay and a DC power 
supply that can be replaced with a battery for portability. 
Typical power requirements for the heating element 16 inte-
grated within the incubator 10 are at the order of just 1 W. To 
enable tissue preservation, the resistive heating element 16, 
can be replaced with a thermoelectric pump, for example, to 
maintain the temperature below the ambient. 
Although not shown, additional sensors and controllers 
including but not limited to glucose consumption, pH or 
dissolved 0 2 sensing and control 18a can be easily integrated 
into the perfusion chamber 30 and the enclosure 11 depend-
ing on particular demand. The modular design allows inte-
gration of all or some of the above mentioned elements and 
enables the packaging of a larger number of perfusion cham-
bers 30 into a common, environmentally regulated enclosure 
11. Higher number of independently controlled perfusion 
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chambers 30, within an enclosure 11 enables high throughput 
processing of a number of cultures onboard a single, dispos-
able platform. 
8 
exit flow collecting pool 41 is slanted to allow the used per-
fusate accumulating in the pool 41 to migrate toward the 
outlet port 34 formed in an exteriorwall 42 of the body 31. A 
6° inclination, for example, of the bottom surface of the pool 
41 helps in steering the used media and catabolites towards 
the outlet port 34. 
The cylindrical sidewall 35 that surrounds the culture 
chamber 20 measures 3.5 mm in diameter and raises 700 µm 
above the perfusion substrate 38 so that the exemplary, effec-
FIG. 2 shows top view of the exemplary microfluidic per-
fusion chamber 30 and a cell culture life support chamber 20. 5 
FIGS. 3 and 4 illustrate three-dimensional views of the per-
fusion chamber 30. FIG. 5 is a cross-sectional view of the 
perfusion chamber 30 and a cell culture chamber 20. FIG. 6 
illustrates a top view showing details of the culture chamber 
20 centrally formed in the perfusion chamber 30. 10 tive volume for 3-D culturing amounts to about 7 µ!.Media 
enters the culture chamber 20 from an array of micronozzles, 
normal to theperfusing substrate 38 (FIG. 6) that upholds the 
tissue, and exits through plurality or radial slots 37 or micro-
As is shown in FIG. 2, the exemplary perfusion chamber 30 
comprises a body 31, which may be made of polydimethyl-
siloxane (PDMS), for example, and a semi-permeable mem-
brane holder 22 that encapsulates the perfusion chamber 30. 
A central opening is formed in the body 31 that defines the 15 
inlet port 33 (FIG. 5) with the exit port 34 embedded into the 
bottom of the return flow (consisting of the used media and 
catabolites) collecting pool 41. The return flow collecting 
pool 41 is formed in the body 31 between cylindrical enclo-
sures 35, 42. The fluidic inlet and outlet ports 33, 34 are 20 
coupled to a syringe pump l9a via inlet and outlet tubing 24, 
25 (shown in FIG. 1). An optically clear membrane 21, such 
as a hydrophobic, fluorinated-polyethylene-propylene (FEP) 
membrane 21, see for example, Potter S. M. et al. in 2001 J 
Neurosci Meth 110: 17-24, is attached to the top of the body 25 
31 via miniature Teflon holder 22 with 0-rings to seal the 
chamber 30 (see FIG. 2). The transparent membrane 21 con-
tacts the top surfaces of the perfusion chamber 30 and culture 
chamber 20 while 0-rings seal the device exterior wall 42 of 
the body 31, and thus the entire perfusion chamber 30. The 30 
FEP membrane 21 is impermeable to the media but perme-
able to gases necessary for cellular metabolism. The trans-
parent membrane 21 secured with a Teflon holder 22 permits 
optical examination or observation of the tissue within the 
culture chamber 20. Such observation is not possible using 35 
conventional, large-scale incubators. Typically, culturing 
takes place in the incubator and tissue has to be taken from the 
refrigerator size incubator to be observed and analyzed under 
a microscope. 
channels 37 formed within the cylindrical enclosure 35 that 
confines the tissue laterally. Exemplary 150 µm wide micro-
channels 37 are 375 µm deep and start at the elevation of375 
µm above the perfusion substrate 38. These microchannels 38 
allow used cell culture media to leave the culture chamber 20. 
The start of the microchannels 38 at a mid-height of the 
cylindrical enclosure 35 enables the tissue to always be at 
least partly submerged. By filling the entire culture chamber 
20 first, without starting the suction, one can ensure that the 
culture is fully submersed prior to the start of a closed-loop 
circulation. The radial exit flow through the microchannel 
array 37 peripherally located within the culturing chamber 20 
is facilitated by the presence of a selectively permeable mem-
brane 21 placed over the top of the perfusion chamber 30. 
While traditional perfusion platforms rely mainly on diffu-
sion and/or capillary action, the incubator 10 disclosed herein 
provides an efficient control of both convective and diffusive 
mass transport relying on interstitial nutrient convection 
induced by an array of microjets issuing from micronozzles 
formed in the perfusing substrate 38 that upholds the tissue 
and peripheral extraction of the perfusate, by an array of 
microchannels 37, for example, located within the cylindrical 
enclosure 35 that laterally confines the tissue. Actively grow-
ing high density cultures are continually perfused with the 
fresh medium. Volumetric flow rates for neuronal-only and 
neuronal/astrocytic co-cultures range from 0.1-0.4 µUmin. 
40 The cell longevity is the dominant factor determining the flow 
rate of the supplied media. Collected perfusate can be mixed 
with the fresh medium and reused, particularly at high 
exchange rates and cell densities when neurotrophins may be 
The body 31, as shown in FIGS. 3 and 4, of the perfusion 
chamber 30 is configured to have a centrally located cylindri-
cal, cell culture life support chamber 20, an outer inclined, 
collecting pool 41, and, fluidic inlet and outlet ports 33, 34 
shown in FIG. 5. The culture chamber 20 as schematically 
shown in FIG. 6 is an actively controlled incubation bath 45 
bounded by the perfusing substrate 38 that supports the tissue, 
located at the bottom of the culture chamber 20, cylindrical 
sidewall 35 that confine the culture to the area immediately 
above the substrate 38, and the optically clear semi-perme-
able membrane 21 attached to the top of the perfusion cham-
ber 30 and held by the Teflon holder 22. A smooth, continu-
ous, circulation of the media and analytes is achieved by using 
a simultaneous push-pull pumping system in which the out-
put exactly balances the input, that is, the culture feedings are 
in mass equilibrium with the amount of retrieved perfusate. 
The level of bathing medium within the culture chamber 20 is 
controlled by the suction side of a syringe pump l9a. Nutri-
ents enter the perfusion chamber 30 through the inlet port 33 
before being distributed through the perfusion substrate 38, 
and further, throughout the volume of the culture chamber 20 
(see FIG. 5). Used media and metabolic waste products are 
withdrawn from the cultured chamber 20 through an array of 
microchannels 37 that are incorporated into the walls of the 
cylindrical PDMS enclosure 35 bounding the culture cham-
ber 20. Retrieved perfusate is collected within the inclined 
pool 41, outside the culture chamber 20, before it is with-
drawn through the outlet port 34. The bottom surface of the 
depleting. 
The perfusing substrate 38 may be made of gold, for 
example, and bonded to or otherwise sealed to the lip formed 
at the bottom of the culture chamber 20. An exemplary gold 
perfusion substrate 38 (such as PELCO® center-marked 
grids, 300 mesh, 1 GG300, for example) measures 3 mm in 
50 diameter and contains 54 µm square openings (micronozzles) 
with center-to-center spacing of85 µm. This yields 40% open 
area for fluid flow. Different perfusion substrates 38, of dif-
ferent topology and surface chemistry for example, may be 
used to promote cellular adhesion to the bottom of the culture 
55 chamber 20 and enable perfusion of the tissue cultured inside. 
Micronozzles can have sub-cellular dimensions, i.e., 5 µm for 
example, which is well below the size of the neural cell body 
(about 10 µm). Various kinds of commercially available or 
custom made substrates 38 having different porosity and 
60 hydraulic diameters, can be bonded to the bottom of the 
culture chamber 20 using a thin layer of PDMS pre-polymer. 
This allows manipulation of the cellular microenvironment 
by altering the flow conditions and cellular adhesion. A vari-
ety ofbiocompatible materials, other than gold, may be used 
65 as perfusion substrates 38 and to support the cells cultured 
within the culture chamber 20. For example, thin nylon mem-
branes, polycarbonate, PTFE, or PLGA films and the like, 
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may be used. In fact, in some cases selective coating of these 
substrates 38 promotes preferential cell growth if desired. 
Cell attachment may be enhanced using a variety ofbiocom-
patible coatings, depending on the exact nature of the study 
and the type of cells cultured within the culture chamber 20. 
For example, dissociated 3-D cultures are often grown in 
protein rich (e.g. matrigel) or polysaccharide based extracel-
lular matrices (e.g. agarose), see for example, O'Connor S. 
M., eta!. in2001 Neurosci Lett304: 189-193; or, Woerly S., et 
al. in 1996 Neurosci Lett 205:197-201. 
The perfusion chamber 30 is aerated by a hydrophobic, 
fluorinated-polyethylene-propylene (FEP) membrane 21 (see 
U.S. Pat. No. 6,521,451, for example) that is selectively per-
meable to gases such as oxygen, nitrogen, hydrogen and 
carbon dioxide and relatively impermeable to microbes, 
water and water vapor (less than 0.01 % moisture absorption). 
Multiple functionalities of the FEP membrane 21 eliminate 
the need to equilibrate the media in an external bath, the most 
frequently used type of aerator ( oxygenator for acute slices) 
used in conventional perfusion chambers, incorporate bubble 
traps, or to include the gas lids to direct the moist and satu-
rated air over the culture like in interface-type (Haas) cham-
bers. Separate buffering of the media to achieve the appropri-
ate acidity is also deemed unnecessary. Hence, the use ofthis 
simple, yet efficient, membrane aerator 21 enables a fine 
control of the cellular climate without complicated, bulky 
components, thus allowing the fabrication of inexpensive 
compact devices. Other benefits of an aerator comprising an 
FEP membrane 21 and a membrane holder 22 include the 
ability to culture in a non-humidified incubator since the 
media does not evaporate from the culture chamber 20 
thereby reducing the risks associated with the contamination 
in a humid environment, and, preventing the increase in 
osmotic strength that can be detrimental to the cultures. Opti-
cally transparent FEP membranes are also impermeable to 
microbes resulting in a reduction of contamination occur-
rences making them ideal for microscopic imaging in a sterile 
environment. 
In all microfluidic devices the purging ofbubbles becomes 
a difficult problem, and while commercially available perfu-
sion chambers usually incorporate external bubble traps, the 
FEP membrane 21 used in the culture chamber 20 enables 
sterile venting of small volumes, i.e., it constitutes an efficient 
auto-venting bubble trap on its own. To further reduce the 
amount of non-dissolved gas bubbles entering the culture 
chamber 20 and equilibrate the fresh media before being 
injected into the perfusion chamber 30, an in-line bubbler/ 
outgassing device can be inserted into the perfusion circuit by 
the use of a tee 26 (e.g. Qosina® 88216 polycarbonate tee 
having medical grade luer ends) and held inside the incubator 
10. 
To assemble the in-line bubbler/outgassing device an FEP 
membrane 27 is stretched over the vertical leg of the tee 26 
having a male luer end, and, sealed with a finger-snap vented 
female luer end-cap (e.g. Qosina® 65702). This device pre-
vents the bubbles from reaching the culture chamber 20, and 
ensures the media equilibrium with the gas environment 
inside the cm-scale incubator 10. To ensure that the media is 
buffered and equilibrated before entering the culture chamber 
20 at high exchange rates, a larger surface area for the in-line 
gas exchange can be obtained alternatively. For example, an 
off-the-shelf filter holder (such as 13 mm Swinnex filter 
holder, Millipore, Billerica, Mass.) may sandwich a 12.7 µm 
thick hydrophobic film (Teflon® FEP film, Dupont, Circlev-
ille, Ohio) and seal it with an 0-ring between the holder top-
and bottom piece. This filter holder with a sandwiched FEP 
membrane 27, as is illustrated in FIG. 8, has a male luer-like 
10 
slip that is received by a tee having a vertical female luer leg 
(e.g. Qosina® 80061 polycarbonate tee). When the inlet to the 
filter is kept in the upright position, the membrane aerator 27 
helps the venting of perfusing lines thus eliminating the need 
for a bubble trap. This also enables a smooth circulation of the 
bathing medium using a syringe-rather than a peristaltic 
pump, as peristaltic pumps generally induce more fluctua-
tions in nutrient delivery. 
The presence of the FEP membrane 21 on the top of the 
10 culture ensures that the plethora of gas is provided from the 
top as is from the bottom via perfusing medium. In addition, 
the PDMS material used in fabricating the chamber 30 is 
found to be highly permeable to oxygen and carbon dioxide 
so that the cellular exposure to the gases is, in fact, enhanced 
15 from all exposed sides of the tissue. Hence, unlike in inter-
face-type chambers where sufficient gas exchange is hindered 
by surface tension induced flow perturbations, the perfusion 
chamber 30 exposes both sides of the tissue to relevant gases 
while keeping the tissue submerged. Compared to Zbicz-type 
20 chambers where submerged tissue may suffer from anoxia 
due to limited water solubility of oxygen for example, in 
culture chamber 20 one side of the tissue is fully exposed to 
the gases above the FEP membrane 21, with the other side 
convectively bathed in equilibrated nutrient medium at high 
25 exchange rates. This enhances the thickness of slices that can 
be investigated in vitro compared to conventional chambers. 
All components of the PDMS perfusion chamber 30 and 
those of relevant fluidics hardware are reusable and steam 
autoclavable, although the low cost of fabrication allows it to 
30 be a disposable device. The inlet and outlet fluidic connec-
tions are removable, i.e. they can be easily pushed in or 
disconnected from the perfusion chamber 30, which facili-
tates the rinsing of tubes and the perfusion chamber 30 prior 
to steam autoclaving them. The inlet and outlet ports 33, 34 
35 are designed to accept standard 3/3211 and 1/1611 barbed, nylon 
adapters with 10-32 male threaded, receiving ports, respec-
tively. These adapters can be either straight-through, for ver-
tical tube connection, or elbow-like, to connect the tubes at a 
side. The adapter type depends on the spatial constraints 
40 during imaging on either upright or inverted microscopes 
with episcopic illumination source, such as epifluorescence. 
An insert plate can be custom made to match a particular 
microscope stage, see exemplary insert plate in FIG. 7, thus 
allowing perfusion experiments, injection of drugs, stimuli, 
45 cytokines and other reagents to be introduced during imaging. 
A receiving tefzel, 10-32 female-to-luer adapters connect to 
polypropylene Luer Tight fittings (Upchurch Scientific). 
These quick-disconnect fittings conform to medical luertaper 
configurations with simple connection to luer lock syringes. 
50 Exemplary fittings accept 1/16" OD semi-rigid fluoropolymer 
tubing such as the inert, Teflon FEP, transparent tubes with 
lOOto 500 µmmicrobores. If soft tubing is to be used, then the 
fittings are less bulky with barbed chamber-to-tube connec-
tors, and, luer-to-barb adapters to connect tubes to syringes. 
55 Barbed fittings require larger bore tubes, thus increasing the 
amount of dead volume in the system, and when the amounts 
of used reagents become important, the use of harder tubes is 
definitely warranted. While the interfacing of the perfusion 
chamber 30 with the cm-scale integrated, diagnostics incu-
60 bator 10 is fairly straightforward, hard tubing facilitates the 
placement of the incubator 10 onto a microscope stage with 
no interruptions to the flow whatsoever. 
Velocity Measurements 
The perfusion chamber 30 and incubator 10 exposes the 
65 cells cultured in a culture chamber 20 to a continuous, direct 
flow of media through an array of micronozzles formed by the 
orifice plate 38 and creates 3-D, convectively biased circula-
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ti on towards the perimeter of the culture chamber 20 where 
perfusate leaves through an array of microchannels 37. The 
flow under consideration is studied experimentally using 
microscopic particle image velocimetry, µ-PIV (see for 
example, Wereley S. T. et al., Micron resolution particle 
image velocimetry, in Diagnostic techniques inmicrofluidics, 
Editor K. Breuer, New York, Springer Verlag, 2004) to obtain 
reliable and reproducible two-dimensional velocity fields in 
the planes normal to the optical axis with high accuracy and 
relatively high spatial resolution. PIV is a well accepted, 
non-intrusive measurement technique where the fluid veloc-
ity is measured by recording the displacement of small tracer 
particles added to the fluid under the assumption that the 
particle density is identical or commensurate to that of the 
surrounding fluid, and its size small enough to follow the flow 
faithfully without influencing the flow itself (low Stokes 
number). Microscopic PIV is a modification of a standard 
PIV technique to enable spatially resolved measurements of 
instantaneous velocity distributions in sub-millimeter scale 
flow domains and allow detection of micron-scale spatial 
structures within the flow. 
In the present experiments velocity resolution is within 5% 
of the microjet ejection velocity. Velocity distributions in the 
x-y planes, parallel to the perufsing substrate 38, and normal 
to the axes of microjets emanating from about 570 square 
micronozzles formed at the perfusing substrate 38, are shown 
in FIGS. 9a-l with the elevation, z, measured from perfusing 
substrate. The field of view measures 450x457 µm and covers 
the central part of the pefusing substrate 38, FIG. 9a, with an 
array of about 6x6 nozzles in focus. The nominal volume flow 
rate through the perfusion chamber is 5 µI/min with micro-jet 
ejection velocity of 30 µmis and a nozzle based Reynolds 
number of 0.002. A small culturing volume (about 7 µ!) 
allows rapid exchange of perfusate (about 40 exchanges per 
hour for the present experiments) facilitates control, and 
reduces the amount of spent media. 
The dynamics of induced flow within the culture chamber 
20 varies with elevation. Spatial structure alters from discrete 
microjets interacting with the stagnant fluid upon their dis-
charge from the micronozzles, jet-to-jet interactions associ-
ated with their broadening as they decelerate downstream 
from the nozzles and exchange momentum with the relatively 
quiescent medium within the culture chamber 20, to stagna-
tion/impingment flow with concomitant development of 
decelerating wall jets (along the FEP membrane 21 or a target 
surface) subject to biased discharge through peripherally 
located microchannel exits 37. 
Close to the perfusing substrate 38 shown in FIG. 9a, flow 
is characterized by semi-confined, submerged, laminar 
impinging microjets issuing from an array of about 570 
micronozzles (formed at the perfusing substrate 38) at mod-
erate target-to-nozzle spacing. Upon their discharge from the 
nozzles, normal to the perfusing substrate 38, microjets inter-
act with the stagnant medium within the culture chamber 20 
12 
With increasing distance from the micronozzles, formed at 
the perfusing substrate 38, discrete, submerged jets, located 
near the center of the culture chamber 20, whose radial 
spreading (normal to the jet axe) at first intensified with the 
elevation now begin to decelerate in the transverse planes, as 
is shown in FIG. 9e, parallel to the perfusing substrate 38. 
This can be seen in FIGS. 9d-e through a reduction in the 
magnitude of the radial microjet velocity at higher distances 
from the perfusing substrate 38. Initially accelerating radial 
10 outflows (closer to the micronozzles) eventually begin to 
decay due to interaction with the zero momentum medium 
within the culture chamber 20 and the presence of spatial 
constraints imposed by surrounding jets and peripheral con-
finement (cylindrical enclosure 35 surrounding the cultured 
15 domain). 
As jets penetrate further into the culture chamber 20, the 
dynamics of the flow changes to incorporate the influence of 
the target surface and peripherally located microchannel exits 
37. Further reduction in jet streamwise momentum causes 
20 their turning from the nominally vertical trajectory and 
adjoining microjets begin to interact prior to their impinge-
ment on the surface of the FEP membrane 21, FIGS. 9f-i. Jet 
interference prior to impingement is likely to be enhanced 
when jets are closely spaced and when the distance between 
25 the nozzle and the impingement plate (nozzle-to-plate dis-
tance) is relatively large. In the presently disclosed flow con-
figuration, this causes the outflows from a number of micro-
jets to merge, FIGS. 9/and 9g, and, begin vectoring towards 
the perimeter of the cultured domain, FIGS. 9h and 9i, at 
30 elevations that are lower than that of the microchannel exits 
37 that start at z=350 µm. This vectoring is influenced by the 
interaction of the induced wall jet (developing along the FEP 
membrane 21) with adjacent impinging microjets. Although 
the spatial arrangement of micronozzles in the array generally 
35 determines the way the microjets interact with each other, a 
strong wall jet originating from the centrally located stagna-
tion zone, FIGS. 9j-l, governs the jet-to-jet interactions with 
increasing distances from the perfusing substrate. 
While in single jet impingement, fully developed wall jet 
40 ultimately decays with increasing distance from the stagna-
tion point due to its radial spreading and rising thickness, (see 
for example Deshpande M. D. et al. in 1982 J Fluid Mech 
114:213-236), the horizontal acceleration of a developing, 
centrally located, wall jet here, continues longer due to merg-
45 ing of outflows from a number of microjets. In fact, this strong 
wall jet deflects the axe of microjets located further away 
from the center of the culture chamber 20 and their impinge-
ment is delayed or even prevented. The induced, biased con-
vection towards the microchannel exits 37 is more pro-
50 nounced in microjets located closer to the cylindrical 
enclosure 35 than those located closer to the center of the 
as demonstrated in the sequence of images in FIGS. 9b-d 55 
normal to the jet axe. This shear driven interaction enables 
them to spread out. Measured spanwise velocity distributions 
reveal that the free boundary of microjets broaden with eleva-
tion, which is manifested by higher magnitudes of the 
induced velocity in the x-y planes, parallel to the perfusing 60 
substrate 38, as jets decelerate streamwise (along their axe) 
and accelerate in transverse planes. Momentum exchange 
between the jets and the stagnant medium causes this broad-
ening with concomitant reduction injet axial (streamwise) 
velocity. Before the jet interactions begin flow symmetry is 65 
determined by the number of microjets, with no apparent 
preferential direction as is shown in FIG. 9d. 
culture chamber 20. Therefore jets emanating closer to the 
center of the culture chamber 20 penetrate deeper into the 
cultured domain than those issuing closer to the enclosure 
walls 35, with the microjet axial flow trajectory reduction 
from the center towards the perimeter. While conventional 
culturing of brain slices in-vitro obtains poor long-term 
viability at the center of the slice, realized flow field in the 
present arrangement facilitates the control of cellular 
microenvironment by providing ample amounts of media to 
the most vulnerable part of the tissue located at the center of 
the culture chamber 20 with the nutrient concentration reduc-
ing towards the lateral sides. Overall, with increasing radial 
coordinate, the axial transport reduces and lateral transport 
increases within the cell culture life-support chamber 20, with 
significant convective enhancement in stagnation and wall jet 
regions over passive diffusion transport mechanism. 
US 7,855,070 B2 
13 
While single impinging jet exhibits three characteristic 
flow domains consisting of a free jet (not influenced by the 
target surface), stagnation and a wall jet region, the closely 
spaced array of impinging jets herein obtains a single, cen-
trally located stagnation zone due to interactions among 
adjoining wall jets and the topology of exit flow. The 
sequence of images in FIGS. 9(j-l) confirm the merging of 
microjet outflows to yield a stagnation point near the centerof 
the FEP membrane aerator 21, with the magnitude of the 
induced velocity (parallel to the perfusing substrate 38) 10 
reducing with the proximity to the impingement plane where 
it reaches zero. Miniature imperfections in the fabrication 
process influence the symmetry of the flow and enhance the 
fluid turning towards the part of the culture chamber 20 where 
the flow resistance is lower. In the present experiments, the 15 
presence of a center mark on the perfusing substrate 38 alters 
the location of the nominally centrally located stagnation 
region, so that it appears slightly off-center. 
Measurements confirm that microjets issuing closer to the 
center of the perfusing substrate 38 penetrate deeper into the 20 
culture chamber 20 specifically targeting the most starved 
part of the tissue, while jet interactions and peripheral with-
drawal of perfusate aid in the establishment of a complex 3-D 
flow within the culture chamber 20. 
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36.8-37.2° C. The PID controller 18 may be coupled to a DC 
switching solid-state relay to regulate the heat flux dissipated 
by the heater 16. Owing to its 7 µI of volume, culture chamber 
20 and the entire perfusion chamber 30 facilitate temperature 
control due to relaxed working conditions and low time con-
stants with negligible delays before parameters reach desired 
values. Small characteristic dimensions of the centimeter-
scale incubator 10 result in negligible losses to the ambient. 
For example, for the heated enclosure 11 to be maintained at 
3 7° C. heater 16 needs to dissipate about 1 W (based on losses 
to the ambient at 20° C.). Likewise, a fraction of a milliWatt 
is needed to warm the media to 3 7° C. at the volume flow rate 
of 7 µI/min (about 1 exchange/minute) with sub-millimeter 
scale heated length through the perfusion chamber 30. 
Temperature measurements inside the mini-incubator 10 
may be taken at four locations, for example, using Fluke 
Hydra data acquisition unit with better than 0.1° C. tempera-
ture resolution. The temperature of the fresh nutrient medium 
is measured just before its injection into the culture chamber 
20 (a thermocouple is placed immediately adjacent to the 
bottom side of the perfusion substrate 38 and routed through 
the media inlet port 33 via inlet tubing 24 and a small tee, and 
sealed). The temperature of the air inside the return flow 
collecting pool 41 may be measured by a thermocouple 
Temperature Measurements 
The perfusion chamber 30 with the centrally forming cul-
ture chamber 20 is placed inside a cm-scale incubator 10 
comprising a polystyrene enclosure 11 using nylon inserts 
such that biocompatible fluidic couplings pass through the 
bottom of the enclosure 11. The heated enclosure 11, which 
may have exemplary outer dimensions of 50x25x18 mm, 
contains a prescribed concentration of gases and maintains 
the temperature of the media and gases at about 37° C. The 
mini-incubator 10 contains a thermofoil heater 16 that heats 
25 routed through the media outlet port 34. The temperature of 
air above the culture chamber 20 (i.e., above the FEP mem-
brane 21) is also measured with the thermocouple routed 
through the side of the optically clear enclosure 11. The 
ambient air temperature outside the mini-incubator 10 is also 
30 measured. FIG. 10 shows graphs that illustrate thermocouple 
temperature measurements following an initial 10-minute 
long controller auto-tuning. FIG. 11 shows graphs that illus-
trate temperature measurements while the incubator is in 
operation. 
For the PID controller 18 to maintain the temperature 
between a low and a high set point (37±0.2° C.), an auto-tune 
is performed during which an optimal set of constants (pro-
portional, integral and differential) is found based on the 
thermal response of the system. After auto-tuning is finished, 
40 a low set point temperature is reached after about 45 minutes, 
as shown in FIG. 10. In operation, the controller 18 utilizes 
this set of parameters to maintain the temperature within a 
prescribed range in response to changes of ambient air tem-
perature. Measurements taken during a 3-hour period, for 
the air inside the incubator 10. Gases necessary for cell 35 
metabolism enter the incubator 10 through its inlet port 12 
(forced by a mini-blower, for example, outside the incubator 
10) and leave through the outlet port 13. Externally located 
and controlled mini blowers 19 force the appropriate gas 
mixture (depending on the cultured tissue) over the heater 16 
located on one side of the enclosure 11. In this configuration, 
gases blow directly onto the surface of the heater 16, and are 
predominantly heated by forced convection inside the mini-
incubator 10. Heated gas warms the perfusion chamber 30 
located downstream from the heater 16. The surface of per-
fusion chamber 30 and the culture chamber 20 reaches the 
thermal equilibrium with surrounding gas within the heated 
enclosure 11 so that the nutrient medium entering the incu-
bator 10 through fluidic coupling inserted into media inlet 33 
(FIGS. 4 and 5), warms up to the prescribed temperature, 
during the slow media advance towards the cell culture cham-
ber 20. 
45 example, demonstrate that the controller maintains the tem-
perature of the media just before injection into the culture 
chamber 20 within the prescribed limits. 
Measurements taken with a given set of parameters a few 
days later, as is shown in FIG. 11, demonstrate that after the 
50 initial warm-up period of the system, the temperature of the 
media remains within the set range over an 8-hour period 
during which measurements are taken. Thermocouple mea-
surements reveal that the controlled media temperature just 
underneath the perfusion substrate 38 follows the tempera-
In operation, the perfusion chamber 30 remains nearly 
isothermal so that the fresh nutrient medium injected into the 
culture chamber 20 through the perfusion substrate 38 
reaches the desired temperature 37±0.2° C. within its fluidic 
inlet port 33 well before entering the cultured volume, with 
the heated length increasing linearly with the flow rate. For 
typical flow rates used in 3-D cell culturing the required 
heated length for the nutrient medium to reach desired tem-
perature within the perfusion chamber 30 is sub-millimeter 
scale, i.e., 1 mm fluidic path through the inlet port 33, for 
example, is enough to warm the injected medium to a pre-
scribed temperature. The temperature of the injected media 
just underneath the perfusion substrate 38 may be measured 
using a thermocouple that is connected to the temperature 
controller 18 to maintain the temperature in the range of 
55 ture of the air inside the outer, collecting pool 41 where used 
media leaves the perfusion chamber 30. 
A more uniform temperature distribution throughout the 
volume of the mini-incubator 10 may be easily obtained by 
insulating the exterior walls with a layer of foam-like tape, for 
60 example. This is also advantageous in preventing the visible 
light from entering the culture chamber 20 and disrupting the 
cells unless optical measurements are under way. 
Multiple perfusion chambers 30 may be integrated within 
a single enclosure 11, for example, each with its own inde-
65 pendent temperature controllers, or using the same controller, 
and gas sources. Several syringes can be used on each side of 
the syringe pump l9a moving block such that each perfusion 
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chamber has an independent set of syringes for the simulta-
neous infusion of the culture medium and the withdrawal of 
catabolic waste products. This permits diagnostic testing of 
multiple samples in parallel without the possibility of cross 
contamination as perfusion chambers 30 are in fact microbe 
impermeable on the gas side. The volume flow rate of injected 
media can be different between adjacent perfusion chambers 
16 
ment, vertical columns that correspond to fluidic connections 
in the finished perfusion chamber 30 usually break from the 
mold base so that thermoplastic templates cannot be reused. 
Posts that remain within released replicas are simply pushed 
through the cast openings within PDMS using a thick needle. 
Depending on size, objects entrapped within released elas-
tomer can be removed by either heating the replicas to melt 
the thermoplastic material followed by suction of the latter, 
or, in case of truly micron scale features by dipping them in 
30 by use of different pairs of syringes for particular cham-
bers. For example, one culture chamber 20 can have exchange 
rate as much as 4 times higher, or more, than the other by 
choosing a syringe pair whose plungers have the surface area 
4 times the surface area of plungers in another pair of 
syringes. 
10 organic solvents (e.g. OS-20 low molecular weight siloxane, 
Dow Coming, Midland, Mich.), thus causing the temporary 
swelling of PDMS and the release of trapped components. 
To further reduce the prototyping costs, disposable, ther-
moplastic masters can be replaced by reusable, polymeric, The scale-down from standard (refrigerator size) incuba-
tors to a cm-scale, portable, integrated, diagnostics incubator 
10 obtains a remarkable physical enhancements such as the 
efficiency in heating or cooling the enclosures as they are 
miniaturized. This facilitates temperature control as heated or 
cooled centimeter-scale incubator obtains faster response 
times to temperature changes due to negligible inertia of an 
inherently miniature device, and, reduces costs associated 
power consumption. 
15 master molds. Reusable templates can be fabricated using a 
"sandwich method", i.e., by encapsulating the prepolymer 
within an extruded box, and, by inserting the cast PDMS 
perfusion chamber 30 into the box face down so that its base 
acts as a box lid. This enclosure box may be extruded using a 
Fabrication Methodology 
20 3-D printer such that the model interior dimensions corre-
spond to the outer dimensions of the PDMS perfusion cham-
ber 30. During insertion of the PDMS perfusion chamber 30 
into the box, the excess prepolymer leaves the mold through 
fluidic openings located on the base of the perfusion chamber Biocompatible and autoclavable, microfluidic perfusion 
chambers 30 may be rapidly prototyped using a process meth-
odology that combines solid object printing and polymer 
replica molding (commonly referred to as the soft lithogra-
phy, see for example Xia Y. and Whiteside G. M. in 1998 
Angewandte Chemie 37:550-575). Custom or commercially 
available perfusion/cell attachment substrates are then sealed 30 
to the bottom of the cultured domain with a PDMS prepoly-
mer, and cured. 
25 30 (box lid). The procedure is straightforward and it takes 
only two sacrificial thermoplastic molds to fabricate a single 
reusable PDMS master. 
Disposable masters for the elastomeric molding, as is 
shown in FIG. 12, are produced by solid-object printing 
(SOP) of an organic thermoplastic (wax-like) polymer that 35 
solidifies upon extrusion based on a defined 3-D CAD mold, 
for example. This convenient inkjet printing tool eliminates 
the need for expensive cleanroom facilities, and, unlike inher-
ently planar 2-D photolithographic techniques, obtains truly 
3-D objects whose feature resolution is 86 µm. Following the 40 
mold design phase, production is virtually hands free as 
printer fabricates the masters, layer by layer, directly onto a 
platform without the use of masks. In a few hours over fifty 
wax molds may be fabricated in a single print. The resolution 
of the commercially available Thermojet printer (3D Sys- 45 
terns, Valencia, Calif.) used herein is 300x400x600 dpi, i.e. 
85, 64 and 24 µminx, y, and, z respectively. For the majority 
of microvascular systems used in bioengineering, this yields 
sufficient feature details and permits quick completion of 
several design iterations, fabrication and testing at a low cost. 50 
The smallest extruded features of the perfusion chamber 
mold is a positive relief forthe elastomeric molding ofl 50 µm 
wide and 350 µm deep microchannels that are reproduced 
faithfully owing to the excellent shape conforming properties 
Favorable PDMS Material Properties 
Polydimethylsiloxane (PDMS) is a rubbery, biologically 
compatible, microfabrication compatible, silicone elastomer 
that is low-cost, and generally non-toxic, non-flannnable, 
thermally stable, chemically inert, optically clear, permeable 
to gases including oxygen and carbon dioxide and almost 
impermeable to water, see for example, Ng J. M. K. et al. in 
2002 Electrophoresis 23:3461-3473. It conforms to submi-
cron features with no discernible pattern degradation or sur-
face distortion upon common biological handling and repre-
sents the material of choice for versatile biological and 
medical applications (see for example, McDonald J. C. et al. 
in 2002 Ace Chem Res 35:491-499; or Whitesides G. M., et 
al. in 2001 Ann Rev Biomed Eng 3:335-373). PDMS prop-
erties offer substantial advantages over fabrication methods 
in hard materials. Molding of 3-D structures in PDMS is 
inexpensive, easy, and a versatile method of making complex 
geometries. The sealing of fluidic devices, coupling of com-
ponents, packaging and interfacing of integrated systems is 
fairly straightforward to employ in PDMS owing to its elas-
ticity, watertight sealing properties and low electrical conduc-
tivity. 
The modular design of the perfusion chamber 30 enables 
the use of commercially available or custom made substrates, 
thus introducing specific topography, flow characteristics and 
surface chemistry intended for particular set of experiments. 
Besides gold, PDMS, SU-8 photopolymer, polymethyl meth-
of the PDMS prepolymer. 55 acrylate (PMMA), and other materials may be used as perfu-
sion/growth substrates upon certain surface treatments that 
render the surfaces cytophilic. Specifically, the ease of PDMS 
topographical and chemical patterning makes it an ideal can-
Upon extrusion of the perfusion chamber molds, a 10: 1 
mixture of the PDMS pre-polymer base and cross-linking 
agent (SYLGARD 184 Silicone Elastomer Kit, Dow Com-
ing, Midland, Mich.) is poured into the wax template, cured at 
room temperature for 48 hours, and, peeled off. The use of 60 
mold release agents was deemed unnecessary owing to favor-
able surface chemistries of materials in contact. However, to 
facilitate the release of cured polymer replicas from deep 
disposable molds, the top of their sidewalls are fabricated at a 
45° angle. This ensures that the upper most layer of the 65 
polymeric PDMS material is entirely peeled-off, thus allow-
ing good grip in stripping subsequent layers. During detach-
didate for perfusion substrate whose shape, texture and sur-
face chemistry can be adjusted to promote cellular adhesion. 
Pulsed plasma deposition of allylamine on hydrophobic poly-
dimethyl-siloxane (PDMS), for example, creates cytophilic 
cell adhesion substrates that can be sterilized using steam 
autoclaving and re-used for several cycles (Harsch A, et al. in 
2000 J Neurosci Meth 98:135-144). Attachment and growth 
of cultured neurons can be manipulated using microcontact 
printing methods that permit the deposition of thin layers of 
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various organic materials on PDMS with varying degree of 
organized architecture. Selective patterning of PDMS sub-
strates may also be necessary to confine cell growth to par-
ticular regions within the culture chamber 20. Silanizing oxi-
dized PDMS with an amino-terminated silane 
( aminopropyltriethoxysilate) provides a reactive surface for a 
bifunctional cross-linker for protein attachment (Bernard A., 
et al. in 2001 Nat Biotechnol 19:866-869). A similar tech-
nique can be employed to attach amino-terminated polyeth-
ylene glycol (PEG) to make the surface stable against surface 
rearrangement and hydrophilic for days in air, e.g., Donze! C., 
et al. in 2001 Adv Mater 13:1164-1168. Bio-fouling, a non-
specific protein adsorption to surfaces such as the interiors of 
micro bore tubes or microchannels, for example, represents a 
common problem in microfluidics as it eventually leads to 
device clogging. Grafting a poly(ethylene glycol)di-(tri-
ethoxy)silane onto an oxidized PDMS surface, the surface of 
PDMS becomes permanently hydrophilic with reduced bio-
fouling properties, see for example Papra A. et al. in 2001 
Langmuir 17: 4090-4095. 
Enabling Qualities and Empowering Functionalities of the 
Centimeter-Scale Diagnostics Incubator with Integrated Per-
fusion 
The disclosed instrumented, portable, centimeter-scale 
incubator 10 represents a striking departure from the standard 
culture environment posing virtually no limits for field appli-
cations with the convenience ofbeing compact, and, flexibil-
ity in design and operation that allows its integration into a 
more robust totally integrated systems. Hence, advantages of 
the miniaturized incubator 10 include (1) reduced size of the 
functional device, (2) flexibility in design, (3) minimized 
response times in pharmacological and biochemical analyses 
owing to microliter volume culture chamber 20, ( 4) low 
expenditures associated with the amount of used reagents, (5) 
reduced production of toxic waster products, ( 6) decreased 
requirements for power, (7) reliable and reproducible opera-
tion owing to relaxed operating conditions associated with 
superior control of physical and chemical parameters in small 
scale devices, (8) increased speed of analyses, (9) the ability 
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parameters are generally preserved resulting in analogous 
biological behavior. Following the scaled-down inertia of the 
system reduces leading to faster response times to chemical 
stimuli and physical changes. This, in turn, offers unprec-
edented control of biological processes due to negligible time 
delays before parameters reach desired, steady state values 
and gives an insight into a real time dynamics of cellular 
responses to stimuli. A reduction in characteristic length scale 
usually results in relaxed operating conditions for sensors and 
10 actuators, often eliminating excessive hardware and high 
power associated with large-scale systems. Hence, unlike 
scaling up, scaling down simplifies incubator operation and 
control thereby substantially lowering costs, allowing paral-
lel processing of multiple samples, and provides higher accu-
15 racy and reproducibility of performed assay analyses. 
Compared to conventional culture tools using Petri dishes 
or multi-well screening plates, the centimeter-scale incubator 
10 with its microliter volume perfusion platform 30 offers 
greater control over the cellular microenvironment. Using 
20 relatively small number of cells at a high plating density, 
cellular response to rapid changes in bathing medium com-
position, application of drugs, or the changes in the extracel-
lular ionic concentration governing the cellular excitability 
can be accurately controlled and easily altered. While rel-
25 evant scientific studies have been hindered by diffusion lim-
ited supply of the nutritive substances and gases necessary for 
cellular metabolism, the perfusion chamber 30 exposes the 
cells to continuous flow of media with rapid exchange rates to 
ensure plethora of nutrients and prevent the metabolic culture 
30 decay. Thus, in the centimeter-scale incubator 10, 3-D cul-
tures can be easily maintained in vitro over extended periods 
of time with sufficient concentration of nutrients and gases at 
an optimal value of acidity and temperature so that the 
humoral states are not altered during the course of an experi-
35 ment. 
to operate in parallel a number of perfusion chambers 30 40 
onboard a single centimeter-scale incubator 10, (11) low-cost 
devices resulting from fabrication of all components onboard 
Concurrent, long-term, bio-culturing with in-situ diagnos-
tics and sample preservation has numerous benefits. Control-
lable field culturing (away from major laboratories), tissue 
growth and analysis on a microscope stand, controllable 
injection of media and trophic factors, biomonitoring and 
biosensing are just a few applications where the mini-incu-
bator 10 with its integrated perfusion chamber(s) 30, optical 
and electrical accessibility are desirable. While perfusion 
chambers with and without environmental control are avail-
a single, disposable platform 30, (12) optical, electrical and 
fluidic accessibility, (13) facile fabrication, packaging, inte-
gration and interfacing, and, (14) portability. 
A reduced-to-practice mini-incubator 10 enables simulta-
neous optical, fluidic and electrical interfacing, and data 
acquisition, in a controlled environment prescribed by the 
temperature, concentration, and flow rate of gases, nutrients 
45 able, e.g., neuronal perfusion, the utility and widespread use 
of these devices is often hindered by metabolically inad-
equate capillary action nutrient delivery, and, their inadapt-
ability to be modular and address a wide range of tasks at a 
or other relevant substances. In an exemplary embodiment, 50 
the temperature of the media inside the incubator 10, just 
before injection into the culture chamber 20, is controlled at 
3 7 ±0.2° C. Associated infrastructure can support a number of 
mini-incubators 10 with their separate perfusion chambers 
30. In-situ diagnostic testing may be performed without dis- 55 
ruption of cultured tissue within separate mini-incubators 10, 
thereby reducing the chances of contamination. 
Growing needs to miniaturize and scale-down cell cultures 
and their microenvironments in vitro from multi-well screen-
ing plates to disposable cell assays for biochemical analyses 60 
for example, in an environment that preserves the culture 
viability and allows in situ monitoring of their physiology, 
small-scale diagnostic incubators with integrated perfusion 
become necessary to manipulate the cellular environment 
down to molecular or cell level. Although surface forces 65 
become dominant following the scale-down in size of con-
ventional systems, the similarities in physical and chemical 
reasonable price. The design of the biocompatible perfusion 
chamber 30 ensures forced convection closed-loop continu-
ous infusion of nutrients and withdrawal of waste with 
enhanced exposure to gases necessary for cell metabolism to 
extend the culture longevity beyond that achieved in large-
scale incubators or small incubation baths. Disposable or 
steam autoclavable perfusion chamber 30 can be easily re-
configured to meet a particular demand with a new device in 
hand in a matter of hours without compromising its simplic-
ity. 
The modular and low-cost design of mini-incubator 10 
facilitates plug-in functionality of various building blocks 
that can be easily integrated (e.g., mixing chambers, nano-
volume multi-port controllable injectors, microelectrode 
arrays, sensors, etc.) and allows operation either in full-scale 
laboratories or in the field, providing a portable, fully self-
contained biological workstation. For example, perfusion 
chamber 30 may enable temporal and spatial control of 
injected agents in addition to continuous delivery of the cell 
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culture media, Customized sample holders can be fitted as 
necessary with fluidic and electrical connectivity to facilitate 
in situ sample manipulation and diagnostics with negligible 
risk of contamination. The modular infrastructure can support 
20 
centration gradients of injected substances into the culture 
chamber 20; the integration of microelectrode arrays for 
physiological studies; biosensors for detection and control of 
small molecules (oxygen, pH, glucose) and large molecules 
(immunosensors ); the capabilities of cooling below the ambi-
ent temperature to preserve the tissue for example; or the 
packaging of a larger number of culture chambers onto a 
common platform. 
Increasing demands for miniature, disposable cellular 
a number of mini-incubators 10 with their separate perfusion 
chambers 30 that can be easily plugged in and out of a cen-
tralized system, providing maximum flexibility in experi-
mental design and minimal capital expenditure. In-situ diag-
nostic testing may be performed within separate incubators 
10, eliminating disruption of other cultured tissue and thereby 
dramatically reducing the chances of contamination. Various 
workstation designs may be constructed and inexpensively 
customized to allow for concurrent optical, fluidic and elec-
trical interfacing to permit full experimental control, includ-
ing data acquisition and individual sample preservation. 
10 essays for long-term pharmacological or biochemical studies 
and tissue engineering require perfused, controllable cellular 
microenvironments. Controllable features include but are not 
limited to: the adjustable shape and texture of the cell culture 
life support chambers, specific surface chemistry or protein 
15 adsorption, and, tunable topography of extracellular matrices 
and chemically patterned microfabricated scaffolds that can 
only be realized in a microfabrication compatible, low-cost, 
mass produced, dynamic perfusion platforms. These require-
ments come in parallel with the needs to reduce the costs 
Thus, in summary, the incubator workstation 10 has opti-
cal, environmental and fluidic accessibility and enables 
simultaneous culturing and analyses on a microscope stand. 
Integrated, actively controlled, perfusion chamber 30 utilizes 
forced convection for intercellular nutrient supply and gas 
exchange thereby allowing the studies of thicker tissue slices 
and dissociated, high-density, three-dimensional (3-D) cul-
tures over extended periods of time. Miniature cell culture life 
support chamber 20 (about 7 µ!) offers relaxed operating 
conditions with superior environmental control and reduced 25 
expenditures associated with harvesting, culture preparation, 
the amount of used reagents and power consumption. A num-
ber of perfusion chambers 30 can be integrated onto a com-
mon platform for high-throughput culture screening with 
reduced risk of contamination. Superior culture aeration is 
achieved two-fold: (i) through an optically clear, microbe and 
water impermeable membrane 21 placed over the top of the 
culture chamber and via (ii) separate in-line venting bubble 
trap 26. A thin membrane 21 that encapsulates the perfusion 
chamber 30 enables efficient gas exchange and keeps the 
tissue moist in a sterile environment. It further reduces the 
risks of contamination by allowing the culturing in non-hu-
midified incubators. The in-line aerator 26 ensures the equi-
librium of the nutrient medium with the gas environment, via 
semi-permeable membrane 27, before being injected into the 
culture chamber 20. This device 26 also serves as an auto-
venting bubble trap that prevents the bubbles from ever reach-
ing the perfusion chamber 30. The use of in-line aerator 26 
eliminates the need for a separate enclosure to equilibrate the 
media and a bubble trap to purge the bubbles, thus greatly 45 
simplifying the design and enabling development of cost-
efficient compact devices. Spatially 42 or temporally varying 
concentrations of injected substances 41 into the culture 
chamber 20 can be dynamically controlled. Additional func-
tionalities including but not limited to glucose consumption, 
pH or dissolved 0 2 sensing and control 18a (FIG. 1) can be 
easily integrated into the device 30. Shape conforming and 
contact sealing properties of the polydimethylsiloxane poly-
mer used in the fabrication of a perfusion chamber 30 enable 
straightforward fabrication of complex three-dimensional 
structures, sealing of devices, coupling of various microflu-
idic and electrical components, packaging and integration 
into functional systems that can be easily interfaced with the 
macro world, see for example Beebe D. J. et al. in 2000 Proc 
Nat! A cad Sci USA 97: 13488-134 93; Chabinyc M. L. et al. in 
2001 Anal Chem 73: 4491-4498; or ZanzottoA. eta!. in2004 
Biotechnol Bioeng 87:243-254. 
The modular design with versatile plug-in-functionalities 
can be tailored to specific use and omitted in particular appli-
cation. These functionalities include but are not limited to: 
microfluidics, e.g. micropumps, valves, mixers and microin-
jectors; introduction of spatially or temporally varying con-
20 associated with the amount of used specimen, biochemicals, 
disposal of waste, excessive hardware associated with large-
scale systems, power consumption, and, repeated analyses 
due to metabolic failures in the absence of functional vascu-
lature and blood supply to the tissue upon harvesting. 
Compared to conventional culture tools using Petri dishes 
or multi-well screening plates, the disposable or autoclavable 
culture chamber 20 measures about 7 µI in volume and offers 
superior control of the cellular microenvironment, see for 
example Vukasinovic J. et al. in 2006 Proceedings of the 2006 
30 ASME Summer Bioengineering Conference. Owing to the 
facile fabrication methodology, straightforward integration 
and packaging, perfusion chamber 30 and the miniature incu-
bator 10 can be easily modified to meet different require-
ments. For example, the ultimate challenge of diagnostic cell 
35 assays is to incorporate biosensors and control loops to moni-
tor temperature, humidity, pH, oxygen or ionic concentration 
in a perfused system with adjustable, spatially selective, 
steady state or temporally varying, velocity or concentration 
gradients, all within a common platform that contains a large 
40 number of cell arrays ready for fundamental studies, optical 
diagnostics, and, intra- or extracellular stimulation and 
recording. Thus this constitutes one of the many applications 
where a centimeter-scale, diagnostics incubator 10 with the 
integrated perfusion chamber 30 can be used. 
Recent interest in totally integrated systems should even-
tually result in development of inexpensive, micro fabricated 
devices with automated dissociation, cellular manipulation 
and diagnostics, see for example Prokop A. et al. in 2004 
Biomed Microdevices 6:325-339. These computer-con-
50 trolled Microsystems will incorporate perfusion chambers, 
incubators, sensors, laminar flow hoods and hardware related 
to cell feeding, counting, etc. on a single, seemingly dispos-
able, platform. The disclosed centimeter-scale incubator 10 
with integrated perfusion is an example of how conventional 
55 (refrigerator size) incubators can be scaled down, and how 
their utility can be empowered with fluidic functionality and 
optical accessibility. Other advantages of the scale-down 
include reduced response times to physical changes and 
chemical stimuli, higher repeatability of performed analyses, 
60 reduced number of cells at high plating densities, low cost 
with minimal volume requirements, and, the possibility for 
parallel processing of many samples onboard a single dispos-
able platform. 
As mentioned in the Background section, the dominant 
65 mode of mass transport in commercially available incubation 
baths remains diffusion and/or capillary action to passively 
augment the supply of media and oxygen to the tissue that 
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eventually runs down metabolically. However, to meet and 
exceed the metabolic requirements for nutrient delivery and 
catabolic waste removal, mass transport by pure diffusion 
becomes insufficient and demands a convective enhancement 
for an adequate, dynamic, long-term control of the culture 
condition. 
22 
tates the control over the composition of the bathing medium, 
its temperature, pH and the degree of oxygenation. Using the 
optical isolation of a pocket-size incubator 10, non-invasive 
sensing methods may be employed in measuring the amount 
of dissolved oxygen and pH using either the commercially 
available sensor foils, or lifetime fluorescence of oxygen and 
pH-sensitive dyes. In either case the sensing infrastructure 
remains outside the incubator enclosure, thus keeping it inex-
pensive, facile to fabricate, and, therefore disposable. The 
Such enhancement is achieved in the novel, perfusion 
chamber 30, where convection based intercellular mass trans-
port can be actively controlled and problems associated with 
the flow perturbations at the interface (Haas chamber), for 
example, or the floating of the tissue and the injection of drugs 
(Zbicz chamber) completely eliminated. Recent experiments 
corroborate the utility of forced convection interstitial nutri-
ent delivery obtained in the perfusion chamber setting 30. An 
efficient circulatory system disclosed herein facilitates the 
studies of thicker organotypic cortical brain slice cultures as 
demonstrated by Rambani K. et al. in 2006 at the Society for 
Neuroscience 36'h Annual Meeting, Neuroscience 2006. The 
integrated membrane 21 and an in-line aerator 26 enable gas 
transport from both sides of the brain slice. 
10 centimeter-scale integrated diagnostics incubator 10 is thus 
portable. Relevant hardware (pump, fan, controllers) may be 
battery operated and the appropriate gas mixture supplied in 
a small bottle. The same incubator 10 can be used to preserve 
biological specimen at a temperature that is below the ambi-
15 ent temperature by replacing the resistive heater with a min-
iature thermoelectric heat pump. 
Portable, optically accessible, centimeter-scale, integrated 
diagnostics incubator for use in biological culturing with 
actively controlled forced convection perfusion has been dis-
20 closed. It is to be understood that the above-described 
The perfusion chamber 30 not only obtained high viability 
of perfused cortical slices, but also the perfusion of nutrient 
medium in larger scale chambers of a similar design proved to 
be a productive tissue engineering setting enabling the growth 
of high-density, physiologically more credible, 3-D tissue- 25 
equivalent constructs. Perfused neuronal-astrocytic co-cul-
tures grown in an extracellular matrix at cell densities close to 
that of the brain tissue (10,000 cells/mm3 ) exhibited over 90% 
viability throughout their thickness (500-750 µm) while non-
perfused, sister-cultures evidenced widespread death as 30 
described by Cullen D. K. et al. in 2006 at the 28rH Annual 
International Conference IEEE Engineering Medicine and 
Biology Society, and by Cullen D. K. et al. in 2006 at the 
Society for Neuroscience 36'h Annual Meeting, Neuro-
science 2006. Note that culture models consisting of multiple 35 
cell types, such as neuronal/astrocytic co-cultures, for 
example, closer approximate the heterogeneity of the in vivo 
tissue. In particular, the heterogeneity of the nervous system 
is better represented through the physical support and the 
metabolic coupling between neurons and astrocytes, e.g. Tsa- 40 
copoulos M. et al. in 1996 JNeurosci 16:877-885, or,Aschner 
M. in 2000 Neurotoxicology 21: 1101-1107. 
One of the empowering aspects of the biocompatible per-
fusion chamber 30 integrated within a centimeter-scale diag-
nostic incubator 10 lies in its straightforward adaptability to 45 
various application challenges by incorporating versatile 
microfluidics and MEMS functionalities with superior con-
trol of pertinent cellular microenvironment than that achieved 
in standard, multi-well screening plates, Petri dishes, or Haas-
or Zbicz-top incubation baths. Other enabling qualities 50 
include the ability to integrate multielectrode arrays or bio-
sensors to monitor physiological functions down to cellular 
level, and, generate complex, steady state e.g. Dertinger S. K. 
W. et al. in 2001 Anal Chem 73:1240-1246, or, temporally 
varying gradients of biologically active substances using 55 
microfluidic networks and different modes of perfusion. By 
actively controlling perfusion, the nature of cell feedings can 
be radically changed to enhance haptotaxis for example, e.g. 
axonal outgrowth and path finding along gradients of diffus-
ible substances containing chemoattractants or repellents, 60 
e.g. Baier H. et al. in 1991 Science 255:472-475. Perfusion 
can be continuous, cyclic in a periodic or an aperiodic fashion 
following a specific control curve, push/pull, and could 
involve the re-use of the spent media for subsequent feedings 
in cases where high-exchange rates may lead to depletion of 65 
trophic factors secreted by the cells to support their own 
growth. Furthermore the dynamic perfusion system 30 facili-
embodiments are merely illustrative of some of the many 
specific embodiments that represent applications of the prin-
ciples discussed above. Clearly, numerous other arrange-
ments can be readily devised by those skilled in the art with-
out departing from the scope of the invention. 
What is claimed is: 
1. Diagnostic incubator apparatus comprising: 
an optically accessible enclosure having a plurality of inlet 
and outlet ports; 
an environmental control element disposed within the 
enclosure that is couplable to an external controller; 
a perfusable sample chamber disposed within the enclo-
sure; 
an optically transparent semi-permeable membrane aera-
tor encapsulating the perfusable sample chamber; and 
convection apparatus that enables forced convection of a 
selected gas and/or liquid medium through the optically 
accessible enclosure and the perfusable sample cham-
ber. 
2. The apparatus recited in claim 1 further comprising: 
apparatus that maintains prescribed pressure within the 
optically accessible enclosure and the perfusable sample 
chamber. 
3. The apparatus recited in claim 1 further comprising: 
apparatus for establishing spatially varying, temporally 
invariant concentration gradients of injected agents 
within the perfusable sample chamber. 
4. The apparatus recited in claim 1 further comprising: 
apparatus for establishing spatially invariant, temporally 
varying concentration gradients of injected agents 
within the perfusable sample chamber. 
5. The apparatus recited in claim 1 further comprising: 
apparatus coupled to selected inlet and outlet ports for 
forcibly convecting a selected medium through the 
enclosure and perfusable sample chamber at a volume 
flow rate that is sufficient to expose a sample disposed 
within the perfusable sample chamber to a concentration 
of the medium that is sufficient to inhibit sample dete-
rioration. 
6. The apparatus recited in claim 1 further comprising: 
an in-line venting device coupled between a selected inlet 
port and the perfusable sample chamber that (1) equili-
brates the liquid medium with the selected gas and pH 
environment prior to its injection into the perfusable 
sample chamber, and (2) removes gas bubbles from the 
liquid medium prior to its injection into the perfusable 
sample chamber. 
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7. The apparatus recited in claim 1 wherein the perfusable 
sample chamber comprises: 
a perfusion substrate containing orifices having a selected 
two-dimensional or three-dimensional topology; 
one or more inlet ports in communication with the sample 
chamber via one or more perfusion substrates; 
a return flow collection chamber in communication with 
the sample chamber; and 
one or more outlet ports coupled to the collection chamber. 
8. The apparatus recited in claim 1 further comprising: 
a plurality of membrane aerated perfusable sample cham-
bers disposed within the enclosure; and 
10 
a plurality of convection apparatus coupled to respective 
perfusable sample chambers for forcibly convecting pre-
determined medium through each of the respective per- 15 
fusable sample chambers. 
9. The apparatus recited in claim 1 which has a size and is 
configured for placement on a microscope stand for manipu-
lation underneath a microscope objective. 
10. The apparatus recited in claim 1 which is a hand-held 20 
portable apparatus adapted for diagnostic field analyses, sam-
pling, sample preservation, and culturing of samples, with 
negligible risk of contamination or cross-contamination of 
the samples, which enhances long-term viability of incubated 
samples, and enables culturing of brain slices on the order of 25 
700 µm thick over at least a 5 day period in vitro. 
11. The apparatus recited in claim 1 which is a hand-held, 
portable, battery operated, apparatus adapted for diagnostic 
field analyses, sampling, sample preservation, and culturing 
of samples, with negligible risk of contamination or cross- 30 
contamination of the samples. 
12. The apparatus recited in claim 1 wherein the perfusable 
sample chamber comprises a culture chamber, a perfused 
culture chamber, a chemotaxis chamber, a haptotaxis cham-
ber, or a sample preservation chamber. 
13. A method for incubating a sample comprising: 
disposing a sample in a perfusable sample chamber that is 
encapsulated by an optically transparent semi-perme-
able membrane aerator; 
35 
disposing the perfusable sample chamber and sample in an 40 
optically accessible enclosure; 
forcibly convecting a selected gas through the enclosure 
and/or perfusable sample chamber and sample; 
forcibly convecting a selected medium through the perfus-
able sample chamber and sample to supply a high con- 45 
centration of the medium throughout the sample; 
continuously removing excess amounts of the medium and 
waste products generated by the sample; and 
24 
18. The method recited in claim 17 further comprising: 
controlling the ratio of newly added medium to recycled 
medium in the perfusable sample chamber. 
19. The method recited in claim 13 further comprising: 
controlling the amount of medium circulated through the 
perfusable sample chamber using a controller that is 
external to the optically accessible enclosure. 
20. The method recited in claim 13 further comprising: 
programmably injecting one or more predetermined bio-
logical or chemical agents into the perfusable sample 
chamber. 
21. The method recited in claim 13 further comprising: 
programmably injecting one or more predetermined agents 
concomitant with continuous infusion of another agent 
into the perfusable sample chamber. 
22. The method recited in claim 13 further comprising: 
programmably injecting one or more predetermined bio-
logical or chemical agents into the perfusable sample 
chamber; and 
removing selected agents from the perfusable sample 
chamber. 
23. The method recited in claim 13 further comprising: 
maintaining pressure within the optically accessible enclo-
sure, sample chamber and sample at a desired level. 
24. The method recited in claim 13 further comprising: 
controlling the volume flow rate of the selected medium 
through the perfusable sample chamber. 
25. The method recited in claim 13 further comprising: 
establishing spatially varying, temporally invariant con-
centration gradients of injected agents within the perfus-
able sample chamber. 
26. The method recited in claim 13 further comprising: 
establishing spatially and temporally varying concentra-
tion gradients of injected agents within the perfusable 
sample chamber. 
27. The method recited in claim 13 further comprising: 
injecting predetermined agents into the perfusable sample 
chamber using separately addressable fluidic inputs, 
interfaced outside the optically accessible enclosure. 
28. The method recited in claim 13 further comprising: 
forcibly convecting a medium equilibrated within the opti-
cally accessible enclosure and the gas at volume flow 
rates that enable culturing of thick organotypic brain 
slices in vitro over an extended period of time. 
29. The method recited in claim 13 further comprising: 
actively controlling the convective, interstitial exchange 
rate of equilibrated media to prevent metabolic decay of 
the sample. 
30. Perfusion apparatus for perfusing a sample, compris-forcibly convecting heat within the optically accessible 
enclosure to maintain a desired sample temperature. 
14. The method recited in claim 13 further comprising: 
circulating the selected gas through the enclosure and/or 
perfusable sample chamber in a closed loop manner, and 
circulating the selected medium through the perfusable 
sample chamber in a closed loop manner. 
50 ing: 
15. The method recited in claim 13 further comprising: 
circulating the selected medium through the perfusable 
sample chamber in a continuous, closed loop manner; 
and 
55 
a perfusion substrate comprising orifices having a selected 
two-dimensional or three-dimensional topology; 
a sample chamber for structurally supporting the sample 
and enabling its attachment to the perfusion substrate; 
one or more inlet port ports in communication with the 
sample chamber through the perfusion substrate; 
a return flow collection chamber in communication with 
the sample chamber; 
removing depleted or used medium and waste products 60 
from the perfusable sample chamber. 
one or more outlet ports coupled to the collection chamber; 
and 
an optically transparent, gas permeable, microbe imperme-
able and substantially water impermeable membrane 
encapsulating the perfusion platform. 
16. The method recited in claim 15 further comprising: 
collecting and analyzing the used medium, sample 
secreted matter and/or waste products. 
17. The method recited in claim 15 further comprising: 
recycling used medium through the perfusable sample 
chamber. 
31. The apparatus recited in claim 30 wherein the perfusion 
65 substrate comprises a screen or grid having a selected poros-
ity, selected two-dimensional or three-dimensional topogra-
phy, or selected surface chemistry for manipulating flow con-
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ditions and/or sample adhesion to the perfusion substrate, 
where the substrate comprises one or more internal surfaces 
of the sample chamber. 
32. The apparatus recited in claim 30 wherein the perfusion 
substrate comprises a material that promotes or inhibits adhe-
sion of a particular constituent of the sample. 
26 
33. The apparatus recited in claim 30 wherein the sample 
chamber contains three-dimensional extracellular matrices, 
microfabricated patterns, or scaffolds that promote cellular 
growth and attachment, direct cell growth, or act as fluidically 
functional injection sites. 
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